306 related articles for article (PubMed ID: 32181368)
1. Localized cocktail chemoimmunotherapy after in situ gelation to trigger robust systemic antitumor immune responses.
Chao Y; Liang C; Tao H; Du Y; Wu D; Dong Z; Jin Q; Chen G; Xu J; Xiao Z; Chen Q; Wang C; Chen J; Liu Z
Sci Adv; 2020 Mar; 6(10):eaaz4204. PubMed ID: 32181368
[TBL] [Abstract][Full Text] [Related]
2. Immunogenic Cell Death Amplified by Co-localized Adjuvant Delivery for Cancer Immunotherapy.
Fan Y; Kuai R; Xu Y; Ochyl LJ; Irvine DJ; Moon JJ
Nano Lett; 2017 Dec; 17(12):7387-7393. PubMed ID: 29144754
[TBL] [Abstract][Full Text] [Related]
3. Three steps to breaking immune tolerance to lymphoma: a microparticle approach.
Makkouk A; Joshi VB; Lemke CD; Wongrakpanich A; Olivier AK; Blackwell SE; Salem AK; Weiner GJ
Cancer Immunol Res; 2015 Apr; 3(4):389-98. PubMed ID: 25627654
[TBL] [Abstract][Full Text] [Related]
4. IL-6 and PD-L1 blockade combination inhibits hepatocellular carcinoma cancer development in mouse model.
Liu H; Shen J; Lu K
Biochem Biophys Res Commun; 2017 Apr; 486(2):239-244. PubMed ID: 28254435
[TBL] [Abstract][Full Text] [Related]
5. Effective chemoimmunotherapy by co-delivery of doxorubicin and immune adjuvants in biodegradable nanoparticles.
Da Silva CG; Camps MGM; Li TMWY; Zerrillo L; Löwik CW; Ossendorp F; Cruz LJ
Theranostics; 2019; 9(22):6485-6500. PubMed ID: 31588231
[TBL] [Abstract][Full Text] [Related]
6. Checkpoint blockade and nanosonosensitizer-augmented noninvasive sonodynamic therapy combination reduces tumour growth and metastases in mice.
Yue W; Chen L; Yu L; Zhou B; Yin H; Ren W; Liu C; Guo L; Zhang Y; Sun L; Zhang K; Xu H; Chen Y
Nat Commun; 2019 May; 10(1):2025. PubMed ID: 31048681
[TBL] [Abstract][Full Text] [Related]
7. PET imaging facilitates antibody screening for synergistic radioimmunotherapy with a
Ren J; Xu M; Chen J; Ding J; Wang P; Huo L; Li F; Liu Z
Theranostics; 2021; 11(1):304-315. PubMed ID: 33391476
[No Abstract] [Full Text] [Related]
8. Generating tumor-selective conditionally active biologic anti-CTLA4 antibodies via protein-associated chemical switches.
Chang HW; Frey G; Liu H; Xing C; Steinman L; Boyle WJ; Short JM
Proc Natl Acad Sci U S A; 2021 Mar; 118(9):. PubMed ID: 33627407
[TBL] [Abstract][Full Text] [Related]
9. Immunostimulatory nanomedicines synergize with checkpoint blockade immunotherapy to eradicate colorectal tumors.
Duan X; Chan C; Han W; Guo N; Weichselbaum RR; Lin W
Nat Commun; 2019 Apr; 10(1):1899. PubMed ID: 31015397
[TBL] [Abstract][Full Text] [Related]
10. Tumor Microenvironment-Activatable Prodrug Vesicles for Nanoenabled Cancer Chemoimmunotherapy Combining Immunogenic Cell Death Induction and CD47 Blockade.
Zhou F; Feng B; Yu H; Wang D; Wang T; Ma Y; Wang S; Li Y
Adv Mater; 2019 Apr; 31(14):e1805888. PubMed ID: 30762908
[TBL] [Abstract][Full Text] [Related]
11. Combining the oncolytic peptide LTX-315 with doxorubicin demonstrates therapeutic potential in a triple-negative breast cancer model.
Camilio KA; Wang MY; Mauseth B; Waagene S; Kvalheim G; Rekdal Ø; Sveinbjørnsson B; Mælandsmo GM
Breast Cancer Res; 2019 Jan; 21(1):9. PubMed ID: 30670061
[TBL] [Abstract][Full Text] [Related]
12. Magnetism-mediated targeting hyperthermia-immunotherapy in "cold" tumor with CSF1R inhibitor.
Fang Y; He Y; Wu C; Zhang M; Gu Z; Zhang J; Liu E; Xu Q; Asrorov AM; Huang Y
Theranostics; 2021; 11(14):6860-6872. PubMed ID: 34093858
[No Abstract] [Full Text] [Related]
13. ATP-Responsive Smart Hydrogel Releasing Immune Adjuvant Synchronized with Repeated Chemotherapy or Radiotherapy to Boost Antitumor Immunity.
Sun L; Shen F; Tian L; Tao H; Xiong Z; Xu J; Liu Z
Adv Mater; 2021 May; 33(18):e2007910. PubMed ID: 33788339
[TBL] [Abstract][Full Text] [Related]
14. Intratumoral CpG-B Promotes Antitumoral Neutrophil, cDC, and T-cell Cooperation without Reprograming Tolerogenic pDC.
Humbert M; Guery L; Brighouse D; Lemeille S; Hugues S
Cancer Res; 2018 Jun; 78(12):3280-3292. PubMed ID: 29588348
[TBL] [Abstract][Full Text] [Related]
15. In situ thermal ablation of tumors in combination with nano-adjuvant and immune checkpoint blockade to inhibit cancer metastasis and recurrence.
Han X; Wang R; Xu J; Chen Q; Liang C; Chen J; Zhao J; Chu J; Fan Q; Archibong E; Jiang L; Wang C; Liu Z
Biomaterials; 2019 Dec; 224():119490. PubMed ID: 31542515
[TBL] [Abstract][Full Text] [Related]
16. Firing Up Cold Tumors.
Cheng WC; Ho PC
Trends Cancer; 2019 Sep; 5(9):528-530. PubMed ID: 31474357
[TBL] [Abstract][Full Text] [Related]
17. Enhanced Antitumor Immunity via Endocrine Therapy Prevents Mammary Tumor Relapse and Increases Immune Checkpoint Blockade Sensitivity.
Sequeira GR; Sahores A; Dalotto-Moreno T; Perrotta RM; Pataccini G; Vanzulli SI; Polo ML; Radisky DC; Sartorius CA; Novaro V; Lamb CA; Rabinovich GA; Salatino M; Lanari C
Cancer Res; 2021 Mar; 81(5):1375-1387. PubMed ID: 33268529
[TBL] [Abstract][Full Text] [Related]
18. Mild photothermal therapy potentiates anti-PD-L1 treatment for immunologically cold tumors via an all-in-one and all-in-control strategy.
Huang L; Li Y; Du Y; Zhang Y; Wang X; Ding Y; Yang X; Meng F; Tu J; Luo L; Sun C
Nat Commun; 2019 Oct; 10(1):4871. PubMed ID: 31653838
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical characterisation of immunological changes at the tumour site after chemo-immunotherapy with doxorubicin, interleukin-2 and interferon-gamma.
Lumsden AJ; Codde JP; Van der Meide PH; Gray BN
Anticancer Res; 1996; 16(3A):1145-54. PubMed ID: 8702226
[TBL] [Abstract][Full Text] [Related]
20. Combined Radiation Therapy and Immune Checkpoint Blockade Therapy for Breast Cancer.
Hu ZI; Ho AY; McArthur HL
Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):153-164. PubMed ID: 28816141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
